Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $22.1 million.

  • Vericel's Cash from Operations rose 11683.03% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.1 million, marking a year-over-year increase of 2854.13%. This contributed to the annual value of $58.2 million for FY2024, which is 6471.64% up from last year.
  • According to the latest figures from Q3 2025, Vericel's Cash from Operations is $22.1 million, which was up 11683.03% from $8.2 million recorded in Q2 2025.
  • In the past 5 years, Vericel's Cash from Operations registered a high of $22.2 million during Q4 2024, and its lowest value of $3.1 million during Q2 2022.
  • In the last 5 years, Vericel's Cash from Operations had a median value of $7.9 million in 2023 and averaged $9.3 million.
  • As far as peak fluctuations go, Vericel's Cash from Operations skyrocketed by 25786.16% in 2021, and later crashed by 6561.57% in 2022.
  • Vericel's Cash from Operations (Quarter) stood at $10.6 million in 2021, then crashed by 33.89% to $7.0 million in 2022, then surged by 44.6% to $10.1 million in 2023, then skyrocketed by 120.52% to $22.2 million in 2024, then fell by 0.72% to $22.1 million in 2025.
  • Its Cash from Operations was $22.1 million in Q3 2025, compared to $8.2 million in Q2 2025 and $6.6 million in Q1 2025.